What We Do

Plexision currently offers cell-based testing for personalized assessment of rejection risk after solid organ transplantation The Pleximmune^TM blood test is the first such test offered for children with liver or intestine transplantation.

Plexision’s technology can be adapted to -

• assess disease risk for several immunological disorders
• predict the success of a drug for a specific patient
• develop dosing recommendations for new immunological drugs